Navigation Links
Dr Stephan Rietiker Joins BioCeramic Therapeutics
Date:1/9/2009

LONDON, January 9 /PRNewswire/ -- UK medical technology company BioCeramic Therapeutics Ltd is delighted to announce that Dr Stephan Rietiker has joined the company's Board of Directors. Dr Rietiker is widely recognized as a leading authority in BioCeramic Therapeutics' targeted sectors, particularly as former President and CEO of Centerpulse (formerly Sulzer Medical). His appointment follows the recent appointment of another renowned figure, Sir Richard Sykes, as Chairman of its Board of Directors and strengthens the company's management as it embarks on a new fundraising round to take its products through clinical trials.

"Given my professional background as a healthcare executive and in particular at Centerpulse, my primary focus is on getting involved in companies with leading edge technologies. As R&D activities in the biomaterials' arena are visibly gaining momentum, I'm delighted to be part of this fascinating venture. I fully believe in the technology and its future potential. Hence, I look forward to supporting the management team in efficiently reaching its strategic milestones and in creating significant value, both for patients and shareholders."

BCT is a pioneer in the exciting new field of regenerative medicine, bringing together some of the world's best materials scientists doctors, biologists and chemists in both private and public sectors. BCT is developing two families of implants designed to promote tissue regeneration. Initial applications are in orthopaedics and oral care, with plans to extend this to a wide range of other tissues important in human diseases.

Daniel Green, BCT's CEO, said: "I am delighted to welcome Stephan to the team. His input will be invaluable as we look to move our first BCT pipeline products through to clinic. Currently we are both exploring several licencing opportunities and embarking on a new fundraising round."

    Corporate 
'/>"/>
SOURCE  BioCeramic Therapeutics Ltd
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 

Related biology technology :

1. Dr. John Stephen Osika, HIV/AIDS and Infectious Disease Expert, Joins Abt Associates
2. GEN Joins Charles Darwin 2009 Celebration
3. BioLife Solutions Joins Prestigious Biomedical Excellence for Safer Transfusion Collaborative
4. Maureen Mo Zilly Joins the Varian Medical Systems Government Affairs Team as Director, Federal Affairs
5. Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins  Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons
6. Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer
7. Pharos Innovations Joins Partnership to Fight Chronic Disease
8. Recognized Dermatology Expert Dr. Zoe Draelos Joins Histogen Scientific Advisory Board
9. Ethan Weiss, M.D., Joins Bionovos Scientific Advisory Board
10. Benjamin Custodio Joins Millennium Biotechnologies to Expand International Sales
11. Jerome Wilson Joins PRA Internationals Late Phase Service Group
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):H1N1 influenza adopted novel strategy to move from birds to humans 2H1N1 influenza adopted novel strategy to move from birds to humans 3H1N1 influenza adopted novel strategy to move from birds to humans 4Superior offspring without genetic modification 2Study finds new relationship between gene duplication and alternative splicing in plants 2Study finds new relationship between gene duplication and alternative splicing in plants 3Palomar to Commercialize FDA Cleared Over The Counter Home Use Wrinkle Treatment Laser Device Without Johnson 26amp 3B Johnson 5536 1Palomar to Commercialize FDA Cleared Over The Counter Home Use Wrinkle Treatment Laser Device Without Johnson 26amp 3B Johnson 5536 2Palomar to Commercialize FDA Cleared Over The Counter Home Use Wrinkle Treatment Laser Device Without Johnson 26amp 3B Johnson 5536 3Palomar to Commercialize FDA Cleared Over The Counter Home Use Wrinkle Treatment Laser Device Without Johnson 26amp 3B Johnson 5536 4Palomar to Commercialize FDA Cleared Over The Counter Home Use Wrinkle Treatment Laser Device Without Johnson 26amp 3B Johnson 5536 5Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 1Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 2Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 3Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 4Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 5Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 6Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 7Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 8Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 9Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 10Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 11Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 12Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 13Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 14Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 15Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 16Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 17Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 18Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 19Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 20Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 21Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 22Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 23Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 24Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 1Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 2Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 3Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 4Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 5Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 6Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 7Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 8Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 9Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 10Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 11